Mediastinitis caused by an NDM-1 Escherichia coli in a child with Dacron Sano shunt after pulmonary atresia with ventricular septal defect surgery treated with combination of aztreonam-avibactam

Int J Antimicrob Agents. 2024 Oct;64(4):107295. doi: 10.1016/j.ijantimicag.2024.107295. Epub 2024 Aug 2.

Abstract

Carbapenem-resistant Enterobacterales are being reported increasingly and cause nosocomial infections, which may include postoperative mediastinitis. This paper reports a case of postoperative mediastinitis caused by an Escherichia coli NDM-1 carbapenemase producer in a 13-month-old boy with DiGeorge syndrome. The infection was managed with surgical debridement and antibiotherapy with aztreonam, ceftazidime-avibactam and IV fosfomycin for 6 weeks. The evolution was favourable, without relapse over 10 weeks of follow-up.

Keywords: Aztreonam; Carbapenem-resistant Enterobacterales; Ceftazidime-avibactam; Mediastinitis; Paediatric; Postsurgical infection.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents* / therapeutic use
  • Azabicyclo Compounds* / therapeutic use
  • Aztreonam* / therapeutic use
  • Ceftazidime / therapeutic use
  • Drug Combinations*
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / microbiology
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Escherichia coli* / isolation & purification
  • Heart Septal Defects, Ventricular / surgery
  • Humans
  • Infant
  • Male
  • Mediastinitis* / drug therapy
  • Mediastinitis* / microbiology
  • Pulmonary Atresia / surgery
  • Treatment Outcome
  • beta-Lactamases* / genetics

Substances

  • Aztreonam
  • beta-Lactamases
  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • Drug Combinations
  • beta-lactamase NDM-1
  • Ceftazidime
  • avibactam